Cholecystectomy and endometrial cancer: A marker of long-term elevated estrogen exposure?

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 1348-1353

  Morimoto, L M ^a   Newcomb, P A ^a,b   Hampton, J M ^b   Trentham Dietz, A ^b  

^a USA   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Cholecystectomy; Endometrial cancer; Gallstones

Indexed keywords

ESTROGEN; GESTAGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; BODY MASS; CHOLECYSTECTOMY; COMMUNITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GALLSTONE; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTION; RISK; RISK FACTOR; SMOKING HABIT;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLECYSTECTOMY; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GALLSTONES; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; TIME;

EID: 33745089878     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00537.x     Document Type: Article

References (53)

1. Barbara L Sama C Morselli-Lebate AM et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987 7: 913 7.
2. Maclure KM Hayes KC Colditz GA Stampfer MJ Speizer FE Willet WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989 321: 536 9.
3. Liddle RA Goldstein RB Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989 149: 1750 3.
4. Schiffman ML Sugerman HJ Kellum JM Brewer WH Moore EW. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991 86: 1000 5.
5. Syngal S Coakley EH Willett WC Byers T Williamson DF Colditz GA. Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 1999 130: 471 7.
6. Ko CW Lee SP. Epidemiology and natural history of common bile duct stones and prediction of disease. Gastrointest Endosc 2002 56 ( Suppl. 6 S165 9.
7. Richardson WS Carter KM Helm B Garcia LA Chambers RB Keats BJ. Risk factors for gallstone disease in the laparoscopic era. Surg Endosc 2002 16: 450 2.
8. Valdivieso V Covarrubias C Siegel F Cruz F. Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium. Hepatology 1993 17: 1 4.
9. Petitti DB Sidney S Perlman JA. Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology 1988 94: 91 5.
10. Scragg RK McMichael AJ Seamark RF. Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease - a case-control study. Br Med J (Clin Res Ed) 1984 288: 1795 9.
11. Simon JA Hunninghake DB Agarwal SK et al. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. Ann Intern Med 2001 135: 493 501.
12. Uhler ML Marks JW Voigt BJ Judd HL. Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women. J Clin Endocrinol Metab 1998 83: 410 4.
13. Greenberger NJ Paumgartner G. Diseases of the gallbladder and bile ducts. In: Braunwald E Fauci AS Kaspar DL Hauser SL Longo DL Jameson JL, eds. Harrison's principles of internal medicine, 15th edn. New York, NY: McGraw-Hill, 2001: 1777 88.
14. Brinton LA Hoover RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Obstet Gynecol 1993 81: 265 71.
15. Brinton LA Berman ML Mortel R et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992 167: 1317 25.
16. Swanson CA Potischman N Wilbanks GD et al. Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. Cancer Epidemiol Biomarkers Prev 1993 2: 321 7.
17. Zeleniuch-Jacquotte A Akhmedkhanov A Kato I et al. Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 2001 84: 975 81.
18. Newcomb PA Trentham-Dietz A Egan KM et al. Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 2001 153: 1071 8.
19. Olsson H Hagglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 1992 136: 422 7.
20. Persson I Adami HO McLaughlin J Naessen T Fraumeni JFJ. Reduced risk of breast and endometrial cancer among women with hip fractures. Cancer Causes Control 1994 5: 523 8.
21. Persson I Naessen T Adami HO et al. Reduced risk of hip fracture in women with endometrial cancer. Int J Epidemiol 1992 21: 636 42.
22. Gudmundsson S Moller TR Olsson H. Cancer incidence after cholecystectomy - a cohort study with 30 years follow-up. Eur J Surg Oncol 1989 15: 113 7.
23. Weiss NS Farewell VT Szekely DR English DR Kiviat N. Oestrogens and endometrial cancer: effect of other risk factors on the association. Maturitas 1980 2: 185 90.
24. Johansen C Chow WH Jorgensen T Mellemkjaer L Engholm G Olsen JH. Risk of colorectal cancer and other cancers in patients with gall stones. Gut 1996 39: 439 43.
25. Lowenfels AB Domellof L Lindstrom CG Bergman F Monk MA Sternby NH. Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden. Gastroenterology 1982 83: 672 6.
26. Beresford SA Coker AL. Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol 1989 130: 202 5.
27. Newcomb PA Trentham-Dietz A. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States). Cancer Causes Control 2003 14: 195 201.
28. Altieri A Pelucchi C Talamini R Bosetti C Franceschi S La Vecchia C. Cholecystectomy and the risk of colorectal cancer in Italy. Br J Cancer 2004 90: 1753 5.
29. Ekbom A Yuen J Adami HO et al. Cholecystectomy and colorectal cancer. Gastroenterology 1993 105: 142 7.
30. Giovannucci E Colditz GA Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993 105: 130 41.
31. Goldbohm RA Van den Brandt PA van't Veer P Dorant E Sturmans F Hermus RJ. Cholecystectomy and colorectal cancer: evidence from a cohort study on diet and cancer. Int J Cancer 1993 53: 735 9.
32. Jorgensen T Rafaelsen S. Gallstones and colorectal cancer - there is a relationship, but it is hardly due to cholecystectomy. Dis Colon Rectum 1992 35: 24 8.
33. Lagergren J Ye W Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 2001 121: 542 7.
34. Mamianetti A Cinto RO Altolaguirre D Bosicio OA Heidenreich A Saloman M. Relative risk of colorectal cancer after cholecystectomy. A multicentre case-control study. Int J Colorectal Dis 1988 3: 215 8.
35. McFarlane MJ Welch KE. Gallstones, cholecystectomy, and colorectal cancer. Am J Gastroenterol 1993 88: 1994 9.
36. Mercer PM Reid FD Harrison M Bates T. The relationship between cholecystectomy, unoperated gallstone disease, and colorectal cancer. A necropsy study. Scand J Gastroenterol 1995 30: 1017 20.
37. Neugut AI Murray TI Garbowski GC et al. Cholecystectomy as a risk factor for colorectal adenomatous polyps and carcinoma. Cancer 1991 68: 1644 7.
38. Reid FD Mercer PM Harrison M Bates T. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 1996 31: 160 9.
39. Schernhammer ES Leitzmann MF Michaud DS et al. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003 88: 79 83.
40. Zeng ZS Zhang ZF. Cholecystectomy and colorectal cancer in China. Surg Oncol 1993 2: 311 9.
41. Goldacre MJ Abisgold JD Seagroatt V Yeates D. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer 2005 92: 298 301.
42. International Agency for Cancer Research. IARC monographs on the evaluation of carcinogenic risks to humans: postmenopausal hormone therapy and hormonal contraception. Lyon, France: IARC Press 1999.
43. Grady D Herrington D Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. JAMA 2002 288: 49 57.
44. Schoff SM Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998 148: 234 40.
45. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol 1984 119: 9 22.
46. Baron JA Byers T Greenberg ER. Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst 1986 77: 677 80.
47. Newcomer LM Newcomb PA Trentham-Dietz A Storer BE. Hormonal risk factors for endometrial cancer: modification by cigarette smoking. Cancer Causes Control 2001 12: 829 35.
48. Weiderpass E Baron JA. Cigarette smoking, alcohol consumption, and endometrial cancer risk: a population-based study in Sweden. Cancer Causes Control 2001 12: 239 47.
49. Goss PE Tye LM. Hormones and cancer. In: Tannock IF Hill RP, eds. The basic science of oncology, 3rd edn. New York, NY: McGraw-Hill, 1998: 263 94.
50. Everson GT McKinley C Kern F. Mechanisms of gallstone formation in women. Effects of exogenous estrogen and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991 87: 237 46.
51. Okura Y Urban LH Mahoney DW Jacobsen SJ Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004 57: 1096 103.
52. Zhu K McKnight B Stergachis A Daling JR Levine RS. Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol 1999 28: 409 17.
53. Feldman M Friedman L Sleisenger M., eds. Sleisenger & Fordtran's gastrointestinal and liver disease, 7th edn. Philadelphia, PA: WB Saunders Company, 2002.